Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models

BACKGROUND: Statins may have therapeutic effects on hepatocarcinoma (HCC). This type of disorder is the most common malignant primary tumour in the liver. Our objective was to determine whether pravastatin had a therapeutic effect in vitro and in vivo models. METHOD: We design in vitro and in vivo m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hijona, Elizabeth, Banales, Jesús María, Hijona, Lander, Medina, Juan Francisco, Arenas, Juan, Herreros-Villanueva, Marta, Aldazabal, Pablo, Bujanda, Luis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Primary Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3298718/
https://ncbi.nlm.nih.gov/pubmed/22353776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-12-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak